Hmmmm...lets see now doesn't Endo market Voltaran Gel? 

Nuvo has a key loan that can be called in the hands of their biggest competitor and that competitor will now be marketing Pennsaid in Canada.

Perhaps positive change will come of all this yet - depends how the loan and product marketing contracts were written to deal with a change of control; standard fare in longer-term deals.

Perhaps Nuvo will comment ...